Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Comparative Analysis of Cardiorenal Effects of Tirzepatide and Dulaglutide in Diabetic Patients with Cardiovascular Conditions

  • By

  • Steven E. Nissen

  • Kathy Wolski

  • David D’Alessio

  • Govinda Weerakkody

  • Jacek Kiljanski

  • Russell J. Wiese

  • Imre Pavo

  • Bertrand Cariou

  • Stephen J. Nicholls

  • June 1, 2026

Share

Original Source(s)

Related Content